| Integrating cellular metabolism into a multiscale whole-body model M Krauss, S Schaller, S Borchers, R Findeisen, J Lippert, L Kuepfer PLoS computational biology 8 (10), e1002750, 2012 | 138 | 2012 |
| A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation C Thiel, S Schneckener, M Krauss, A Ghallab, U Hofmann, T Kanacher, ... Journal of pharmaceutical sciences 104 (1), 191-206, 2015 | 123 | 2015 |
| Development of a whole-body physiologically based pharmacokinetic approach to assess the pharmacokinetics of drugs in elderly individuals JF Schlender, M Meyer, K Thelen, M Krauss, S Willmann, T Eissing, ... Clinical pharmacokinetics 55, 1573-1589, 2016 | 113 | 2016 |
| Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification M Krauss, R Burghaus, J Lippert, M Niemi, P Neuvonen, A Schuppert, ... In Silico Pharmacology 1, 1-11, 2013 | 66 | 2013 |
| Spatio-temporal simulation of first pass drug perfusion in the liver LO Schwen, M Krauss, C Niederalt, F Gremse, F Kiessling, A Schenk, ... PLoS computational biology 10 (3), e1003499, 2014 | 61 | 2014 |
| Bayesian population physiologically-based pharmacokinetic (PBPK) approach for a physiologically realistic characterization of interindividual variability in clinically relevant … M Krauss, K Tappe, A Schuppert, L Kuepfer, L Goerlitz PloS one 10 (10), e0139423, 2015 | 58 | 2015 |
| Characterization of statin dose response in electronic medical records WQ Wei, Q Feng, L Jiang, MS Waitara, OF Iwuchukwu, DM Roden, ... Clinical Pharmacology & Therapeutics 95 (3), 331-338, 2014 | 34 | 2014 |
| Translational learning from clinical studies predicts drug pharmacokinetics across patient populations M Krauss, U Hofmann, C Schafmayer, S Igel, J Schlender, C Mueller, ... NPJ systems biology and applications 3 (1), 11, 2017 | 16 | 2017 |
| A multiscale, model-based analysis of the multi-tissue interplay underlying blood glucose regulation in type I diabetes F Wadehn, S Schaller, T Eissing, M Krauss, L Küpfer 2016 38th Annual International Conference of the IEEE Engineering in …, 2016 | 12 | 2016 |
| Assessing interindividual variability by Bayesian-PBPK modeling M Krauss, A Schuppert Drug Discovery Today: Disease Models 22, 15-19, 2016 | 9 | 2016 |
| Predicting morphine drug exposure in elderly using an age-informed physiologically based pharmacokinetic approach JF Schlender, M Meyer, K Thelen, M Krauss, M Block, S Willmann, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 43, S100-S100, 2016 | | 2016 |
| Bayesian population PBPK approach for support of drug development M Krauß, A Schuppert, A Mitsos Lehrstuhl für Datengetriebene Modellierung in der Computational Engineering …, 2016 | | 2016 |
| Virtueller Blutfluss: die Leber in silico LO Schwen, M Krauss, C Niederalt Journal Club AINS 3 (02), 107-107, 2014 | | 2014 |
| Characterization of Statin Dose-response within Electronic Medical Records M Krauss Clin Pharmacol Ther 95 (3), 331-338, 2014 | | 2014 |
| Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess The JF Schlender, M Meyer, K Thelen, M Krauss, S Willmann, T Eissing, ... | | |
| A SPATIO-TEMPORALLY RESOLVED HEPATIC PHARMACOKINETICS MODEL LO Schwen¹, M Krauss, F Gremse, F Kiessling, T Preusser¹, L Küpfer | | |
| Please select your preffered valuta to pay M Krauß | | |
| Population Approach Group Europe Population Approach Group Europe C Diedrich | | |
Professor Lars KuepferInstitute for systems medicine with focus on organ interaction, RWTH Aachen在 rwth-aachen.de 的电子邮件经过验证
